The Oncology Institute, Inc. (TOIIW)

0.0603

+0.0135

+(28.85%)

As of 11:32:35 AM EDT. Market Open.

The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call

CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financial results after the market close on Wednesday, May 14, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers,

GlobeNewswire 3 hours ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials

CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with Helios Clinical Research, a nationally recognized research site network. This initiative builds upon a successful collaboration in Florida and reflects TOI’s ongoing commitment to integrating clinical research into community oncology settings.

GlobeNewswire 19 hours ago

TOI
+2.03%
TOIIW
+28.85%
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1

CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents. The Florida Oncology Network includes TOI Clinics and a robust panel of value-focused medical and radiation oncolog

GlobeNewswire 23 days ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ...

The Oncology Institute Inc (TOI) reports a 21% annual revenue increase, while addressing profitability challenges and setting optimistic guidance for 2025.

GuruFocus.com 28 days ago

TOI
+2.03%
TOIIW
+28.85%
Oncology Institute Full Year 2024 Earnings: US$0.86 loss per share (vs US$0.92 loss in FY 2023)

Oncology Institute ( NASDAQ:TOI ) Full Year 2024 Results Key Financial Results Revenue: US$393.4m (up 21% from FY...

Simply Wall St. 29 days ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025

CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024. Recent Operational Highlights Cash flow from operations in Q4 2024 was approximately $4.2 million, due to disciplined working capital management that saw improvements across receivables, inventory, and payable

GlobeNewswire 30 days ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Announces $16.5 million Private Placement

CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors for a private placement that is expected to result in gross proceeds of approximately $16.5 million, before deducting placement agent fees and offering expenses (the “

GlobeNewswire 30 days ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for interna

GlobeNewswire last month

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown

CERRITOS, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced an amendment to its existing facility agreement with funds affiliated with Deerfield Management Company, L.P. (“Deerfield”), an investment firm committed to advancing healthcare, as well as a partial paydown of the senior secured convertible notes. Under the amendment, Deerfield agre

GlobeNewswire last month

TOI
+2.03%
TOIIW
+28.85%
Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying

Insiders who bought The Oncology Institute, Inc. ( NASDAQ:TOI ) stock in the last 12 months were richly rewarded last...

Simply Wall St. 2 months ago

TOI
+2.03%
TOIIW
+28.85%
Florida Blue enhances cancer care for thousands of members

New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology careJACKSONVILLE, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Florida Blue, the state's leading health insurer, has launched a new comprehensive oncology care model designed to provide faster access to high-quality cancer care for its myBlue members. This patient-centric program, jointly developed by Florida Blue, Sanitas Medical Centers, and The Oncology Insti

GlobeNewswire 4 months ago

TOI
+2.03%
TOIIW
+28.85%
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023)

Oncology Institute ( NASDAQ:TOI ) Third Quarter 2024 Results Key Financial Results Revenue: US$99.9m (up 22% from 3Q...

Simply Wall St. 5 months ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Reports Third Quarter 2024 Financial Results

CERRITOS, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and nine months ended September 30, 2024. Recent Operational Highlights Include 79.9% increase in Dispensary segment revenue compared to prior year quarterWelcomed Rob Carter, as our new Chief Financial Officer3 new capitation contracts signed across 2

GlobeNewswire 5 months ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California

TOI will be one of the few community-based practices on the West Coast to offer radiopharmaceuticals in the outpatient setting.CERRITOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) announced that they have received certification to begin administering Pluvicto therapy in their outpatient California radiation oncology practices. Pluvicto, a radiopharmaceutical used to treat certain types of metastatic prostate cancer, has previous

GlobeNewswire 5 months ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2024 financial results after the market close on Wednesday, November 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international calle

GlobeNewswire 5 months ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence

CERRITOS, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, has joined Lantern’s leading specialty care platform. Now, Lantern members will have access to cancer care at any of The Oncology Institute’s state-of-the-art community clinics across 5 states. “At TOI, we believe that every cancer patient deserves access to the most advanced care in their community,” said Dr. Dan Virnich, Chief Executive O

GlobeNewswire 5 months ago

TOI
+2.03%
TOIIW
+28.85%
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

CERRITOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) shared its partnership with the American Journal of Managed Care® (AJMC) to co-host a symposium focused on value-based cancer care. The event will take place on October 24, 2024, in Miami, Florida, as part of AJMC’s Institute for Value-Based Medicine (IVBM). The IVBM serves as a premier forum where leading expert faculty share their insights and experiences in implementing val

GlobeNewswire 6 months ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute of Hope & Innovation Launches Oregon Market

Anchor value-based payor partnership leads to opening of locations in Portland and SalemCERRITOS, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, is proud to announce its expansion into Oregon with the opening of two new specialty cancer clinics. The clinic locations in Portland and Salem will mark TOI’s first capitated partnership in the market, with plans to expand to other markets in the state

GlobeNewswire 6 months ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Announces CFO Transition

Rob Carter promoted to Chief Financial OfficerCERRITOS, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), today announced that Chief Financial Officer, Mihir Shah, will transition out of the organization effective October 14, 2024, to pursue other opportunities. Rob Carter, Senior Vice President of Finance at TOI, will be promoted to Chief Financial Officer. Mr. Carter brings over a decade of finance leadership experience across sever

GlobeNewswire 6 months ago

TOI
+2.03%
TOIIW
+28.85%
The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

CERRITOS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and six months ended June 30, 2024 and updated its full year 2024 guidance. Recent Operational Highlights Include 76% increase in Dispensary segment revenue compared to prior year quarter3 new capitation contracts signed across 2 states including both m

GlobeNewswire 8 months ago

TOI
+2.03%
TOIIW
+28.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

The Oncology Institute, Inc. (TOIIW)

The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call

The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials

TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1

The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ...

Oncology Institute Full Year 2024 Earnings: US$0.86 loss per share (vs US$0.92 loss in FY 2023)

The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025

The Oncology Institute Announces $16.5 million Private Placement

The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown

Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying

Florida Blue enhances cancer care for thousands of members

Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023)

The Oncology Institute Reports Third Quarter 2024 Financial Results

The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California

The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence

The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

The Oncology Institute of Hope & Innovation Launches Oregon Market

The Oncology Institute Announces CFO Transition

The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance